Profund Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-51,455
Closed -$228K 1048
2024
Q4
$228K Sell
51,455
-30,914
-38% -$137K 0.01% 936
2024
Q3
$339K Buy
82,369
+6,986
+9% +$28.8K 0.01% 726
2024
Q2
$491K Sell
75,383
-86,472
-53% -$564K 0.02% 502
2024
Q1
$1.41M Buy
161,855
+42,371
+35% +$369K 0.05% 252
2023
Q4
$1.37M Sell
119,484
-31,795
-21% -$364K 0.06% 264
2023
Q3
$1.46M Buy
151,279
+14,299
+10% +$138K 0.08% 194
2023
Q2
$1.46M Buy
136,980
+15,485
+13% +$165K 0.08% 220
2023
Q1
$1.28M Buy
121,495
+103,109
+561% +$1.08M 0.08% 233
2022
Q4
$228K Buy
18,386
+181
+1% +$2.24K 0.01% 828
2022
Q3
$189K Sell
18,205
-3,322
-15% -$34.5K 0.01% 837
2022
Q2
$248K Buy
21,527
+7,261
+51% +$83.7K 0.02% 760
2022
Q1
$179K Sell
14,266
-966
-6% -$12.1K 0.01% 1287
2021
Q4
$178K Buy
15,232
+663
+5% +$7.75K 0.01% 1298
2021
Q3
$190K Sell
14,569
-1,585
-10% -$20.7K 0.01% 1269
2021
Q2
$208K Buy
16,154
+762
+5% +$9.81K 0.01% 1330
2021
Q1
$172K Buy
15,392
+928
+6% +$10.4K 0.01% 1278
2020
Q4
$165K Buy
14,464
+735
+5% +$8.39K 0.01% 1131
2020
Q3
$123K Sell
13,729
-723
-5% -$6.48K 0.01% 911
2020
Q2
$149K Buy
14,452
+933
+7% +$9.62K 0.01% 871
2020
Q1
$136K Sell
13,519
-2,039
-13% -$20.5K 0.01% 679
2019
Q4
$207K Buy
15,558
+2,777
+22% +$36.9K 0.01% 1158
2019
Q3
$110K Sell
12,781
-1,756
-12% -$15.1K 0.01% 1242
2019
Q2
$159K Sell
14,537
-2,186
-13% -$23.9K 0.01% 1160
2019
Q1
$190K Sell
16,723
-10,691
-39% -$121K 0.01% 1144
2018
Q4
$238K Sell
27,414
-4,425
-14% -$38.4K 0.01% 927
2018
Q3
$492K Buy
+31,839
New +$492K 0.02% 834